한글목차

중동 및 아프리카의 블리스터 포장 시장은 예측 기간 동안 CAGR 5.2%를 기록할 것으로 예상됩니다.

주요 하이라이트

• 블리스터 팩은 소형 소비재, 식품 및 의약품에 사용되는 여러 종류의 사전 성형 플라스틱 포장의 총칭입니다. 이러한 포장 솔루션은 습기 및 오염과 같은 외부 요인으로부터 제품을 장기간 보호하는 데 유용합니다. 또한 불투명 블리스터는 빛에 민감한 제품을 자외선으로부터 보호합니다. 이러한 다양한 용도가 시장에서 견인차 역할을 하고 있습니다.
• 질병의 증가와 위조 의약품에 대한 정부의 엄격한 규제로 인해 제약회사가 제조된 목적에 대한 효능을 유지해야 한다는 기본적 필요성을 넘어, 모방하기 어려운 명확한 패키지의 의약품을 생산해야 한다는 압력이 증가하고 있는 것이 시장 성장의 주요 요인 중 하나입니다. 시장을 주도하는 주요 요인 중 하나입니다. 블리스터 포장은 지폐 인증 시스템과 같은 위조 방지 시스템의 효율적인 방법을 제공합니다.
• 제조업체, 소비자 및 규제 기관의 제품 안전에 대한 요구가 증가함에 따라 블리스터 포장은 점점 더 실용적인 선택이 되고 있습니다. 대부분의 소비자들이 무방비 상태의 의약품에 유해할 수 있는 온도 변화가 심한 환경에서 의약품을 보관하고 있다는 점을 고려할 때, 제품 무결성 및 유통기한 연장과 같은 요소는 의약품 부문에 매우 필요한 요소입니다.
• 안전 규정 준수에 대한 필요성이 높아지면서 편리하고 사용하기 쉬운 포장 제품에 대한 수요가 증가함에 따라 조사 대상 시장의 성장이 촉진될 것으로 예상되며, 이에 따라 시장 공급업체들이 기술 회사와 협력하여 이러한 기능을 도입하고 대량 구매자를 위한 제품 차별화 이점을 확대할 것으로 예상됩니다. 확대할 것으로 예상됩니다.
• 또한, 이 지역에서는 친환경 블리스터 포장이 주도적인 역할을 하고 있습니다. 예를 들어, Sonoco는 플라스틱 블리스터 포장의 대안으로 소매 포장용 종이 블리스터 "EnviroSense"를 제공하고 있습니다. 또한 소노코는 2025년 말까지 플라스틱 사용을 줄이는 것을 목표로 하고 있습니다.

중동 및 아프리카의 블리스터 포장 시장 동향

의약품은 큰 폭의 성장이 예상됨

영문목차

The MEA Blister Packaging Market is expected to register a CAGR of 5.2% during the forecast period.

Key Highlights

• Blister pack is a term for several types of pre-formed plastic packaging used for small consumer goods, foods, and pharmaceuticals. These packaging solutions are useful for protecting products against external factors, such as humidity and contamination, for extended periods of time. Opaque blisters also protect light-sensitive products against UV rays. Such a wide base of applications has helped it gain traction in the market.
• Increasing pressure on pharmaceutical companies to manufacture medicines that are distinct in packaging and hard to imitate, beyond the basic need of keeping it effective for the purpose it was produced, for it to be made available for patients, owing to rise in diseases and stringent government regulations against counterfeit drugs, are among the major factors propelling the market. Blister packaging offers an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
• The rising need for a level of product safety from manufacturers, consumers, and regulatory organizations makes blister packaging an increasingly practical option. Factors like product integrity and extended shelf life are highly necessary for the pharmaceutical sector, considering that most consumers store their drugs in a temperature variant atmosphere that can be harmful to unprotected medicines.
• The growing need for compliance with safety regulations, coupled with increased demand for convenient and easy-to-use packaging products, is also expected to drive the growth of the market studied and result in the market vendors partnering with technology companies to introduce those features and widen their product differentiation advantages for bulk purchasers.
• Moreover, the region is witnessing traction for eco-friendly blister packaging. For example, Sonoco offers EnviroSense, a paper blister for retail packaging, and is designed as an alternative to plastic blister packages. Additionally, with this, the comany has aimed to reduce the use of plastic by the end of 2025

MEA Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

• The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine. These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
• When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
• The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
• Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry.
• For Example, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
• However, due to the supply chain disruption caused due to the impact of COVID-19, the exports of pharmaceutical products decreased across Africa in 2020. For instance, according to Trade Map, the value of pharmaceutical products exported from Morocco reduced to USD 109.9 million in 2020 compared to USD 117.08 million in 2019.

Africa to hold the Largest Market Share

• Blister packaging in the country is widely used to contain the APIs manufactured by various CMO vendors. In the MEA region, South Africa is known as one of the largest CMO markets in Africa. Some of the major factors responsible for South Africa's attractive pharmaceutical contract manufacturing are its well-established and stable markets and high turnover to investments.
• The tax structures and duties are possible challenges for foreign companies that aim to enter the market. On the other hand, increasing governmental support, rising health expenditure, and initiatives taken to support innovations in drug formulation and pharmaceutical interest are expected to bolster the opportunities available in the country.
• Moreover, Nigeria is one of the most promising and rapidly growing pharmaceutical manufacturing regions in West Africa, with more than 150 pharmaceutical formulation manufacturing facilities. The major drivers of growth in pharmaceutical contract manufacturing are cost advantage, increased demand for biological production, government regulations, and patent expiry.

MEA Blister Packaging Industry Overview

The Middle East and Africa Blister Packaging are highly concentrated. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing products that are acceptable in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.

• April 2021- Amcor announced customer trials for recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
• July 2021 - Huthamaki launched Push Tab paper-based blister solution for the healthcare industry. The paper used by the comany is FSC certified and acts as an alternative to traditional push-through packaging made of thermoformed PVC and aluminum, thus reducing the environmental impact across the value chain.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing geriatric population and prevalence of diseases
  • 4.2.2 Product innovations such as downsizing coupled with relatively low costs
• 4.3 Market Challenges
  • 4.3.1 Dynamic nature of regulations and inability to support heavy goods
• 4.4 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.4.1 Bargaining Power of Suppliers
  • 4.4.2 Bargaining Power of Consumers
  • 4.4.3 Threat of New Entrants
  • 4.4.4 Intensity of Competitive Rivalry
  • 4.4.5 Threat of Substitutes
• 4.5 Assessment of the impact of COVID-19 on Blister Packaging Market

5 MARKET SEGMENTATION

• 5.1 By Process
  • 5.1.1 Thermoforming
  • 5.1.2 Coldforming
• 5.2 By Material
  • 5.2.1 Plastic Films
  • 5.2.2 Paper and Paperboard
  • 5.2.3 Aluminum
  • 5.2.4 Other Materials
• 5.3 By End-User Industry
  • 5.3.1 Consumer Goods
  • 5.3.2 Pharmaceutical
  • 5.3.3 Industrial
  • 5.3.4 Other End-User Industries
• 5.4 By Country
  • 5.4.1 Saudi Arabia
  • 5.4.2 United Arab Emirates
  • 5.4.3 South Africa
  • 5.4.4 Other Regions in Middle East and Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Amcor PLC
  • 6.1.2 MTS Medication Technologies
  • 6.1.3 Constantia Flexibles GmbH
  • 6.1.4 Sonoco Products Company
  • 6.1.5 Klockner Pentaplast Group
  • 6.1.6 Du Pont De Nemours and Company
  • 6.1.7 Honeywell International Inc.
  • 6.1.8 The Dow Chemical Company

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET